Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

Item
http://www.wikidata.org/entity/Q40633555
Molecular surveillance of European quinolone-resistant clinical isolates of Pseudomonas aeruginosa and Acinetobacter spp. using automated ribotyping.Phenotypic resistance of Staphylococcus aureus, selected Enterobacteriaceae, and Pseudomonas aeruginosa after single and multiple in vitro exposures to ciprofloxacin, levofloxacin, and trovafloxacinDelafloxacin for the treatment of respiratory and skin infections.Dead bugs don't mutate: susceptibility issues in the emergence of bacterial resistance.Global fluoroquinolone resistance epidemiology and implictions for clinical use.Resistance surveillance studies: a multifaceted problem--the fluoroquinolone example.Development of novel antibacterial drugs to combat multiple resistant organisms.In vitro antibacterial activities of DQ-113, a potent quinolone, against clinical isolates.QSAR and pharmacophore analysis on amides against drug-resistant S. aureus.
P2860

Quinolone resistance in Pseudomonas aeruginosa and Staphylococcus aureus. Development during therapy and clinical significance.

Item
http://www.wikidata.org/entity/Q40633555
description
1994 nî lūn-bûn
@nan
1994年の論文
@ja
1994年論文
@yue
1994年論文
@zh-hant
1994年論文
@zh-hk
1994年論文
@zh-mo
1994年論文
@zh-tw
1994年论文
@wuu
1994年论文
@zh
1994年论文
@zh-cn
name
Quinolone resistance in Pseudo ...... apy and clinical significance.
@en
type
label
Quinolone resistance in Pseudo ...... apy and clinical significance.
@en
prefLabel
Quinolone resistance in Pseudo ...... apy and clinical significance.
@en
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P478
P577
P698
P921
P356
P1433
P1476
Quinolone resistance in Pseudo ...... apy and clinical significance.
@en
P2093
P2860
P2888
P304
P31
P356
P478
P577
P698
P921